Gene · 10498
Papers2,160
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,160
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Erratum: A CRISPR/Cas9 library screening identifies CARM1 as a critical inhibitor of ferroptosis in hepatocellular carcinoma cells. | Mol Ther Nucleic Acids | 2025 | 40270903 | PubTator, text mining | PubMed |
| Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy. | Mol Ther Oncol | 2025 | 40231187 | PubTator, text mining | PubMed |
| The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts. | Sci Transl Med | 2025 | 40203080 | PubTator, text mining | PubMed |
| The Cognivue Amyloid Risk Measure (CARM): A Novel Method to Predict the Presence of Amyloid with Cognivue Clarity. | Neurol Ther | 2025 | 40192926 | PubTator, text mining | PubMed |
| Cardiomyocyte-Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 Deubiquitination. | Adv Sci (Weinh) | 2025 | 40192103 | PubTator, text mining | PubMed |
| N6-methyladenosine-mediated upregulation of H19 promotes resistance to bortezomib by modulating the miR-184/CARM1 axis in multiple myeloma. | Clin Exp Med | 2025 | 40167832 | PubTator, text mining | PubMed |
| L-arginine dependence of breast cancer - molecular subtypes matter. | BMC Cancer | 2025 | 40140975 | PubTator, text mining | PubMed |
| CARM1 S217 phosphorylation by CDK1 in late G2 phase facilitates mitotic entry. | Cell Death Dis | 2025 | 40133267 | PubTator, text mining | PubMed |
| Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs. | Mol Ther Oncol | 2025 | 40123976 | PubTator, text mining | PubMed |
| A long journey to the discovery of nuclear receptor coactivator existence, physiology, pathology, and therapy. | J Biol Chem | 2025 | 40090583 | PubTator, text mining | PubMed |
| The asymmetric expression of HSPA2 in blastomeres governs the first embryonic cell-fate decision. | Elife | 2025 | 40063400 | PubTator, text mining | PubMed |
| Design, synthesis and evaluation of pyrimidinobenzylamide and pyrimidinothiophenamide derivatives as inhibitors of DOT1L and related epigenetic targets DNMT3a, PRMT4 and other HMTs. | RSC Med Chem | 2025 | 40061000 | PubTator, text mining | PubMed |
| CARM1 regulates tubulin autoregulation through PI3KC2α R175 methylation. | Cell Commun Signal | 2025 | 40045375 | PubTator, text mining | PubMed |
| Exploring genetic loci linked to COVID-19 severity and immune response through multi-trait GWAS analyses. | Front Genet | 2025 | 40034745 | PubTator, text mining | PubMed |
| PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1. | Cell Death Dis | 2025 | 40016178 | PubTator, text mining | PubMed |
| PRMT3 and CARM1: Emerging Epigenetic Targets in Cancer. | J Cell Mol Med | 2025 | 39964832 | PubTator, text mining | PubMed |
| Metformin inhibits the histone methyltransferase CARM1 and attenuates H3 histone methylation during gluconeogenesis. | J Biol Chem | 2025 | 39922487 | PubTator, text mining | PubMed |
| Assessment of PRMT6-dependent alternative splicing in pluripotent and differentiating NT2/D1 cells. | Life Sci Alliance | 2025 | 39900436 | PubTator, text mining | PubMed |
| TAZ interactome analysis using nanotrap-based affinity purification-mass spectrometry. | J Cell Sci | 2025 | 39898439 | PubTator, text mining | PubMed |
| Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer. | Cancer Res Commun | 2025 | 39699269 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10498/papers?page=5